Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
allogeneic adipose derived mesenchymal stem cell (1 trial)
Key: Cesca Therapeutics, Inc. (0) Acquired (1)
platelet rich plasma (1 trial)
Ischemia (Phase 3)
Trials (2 total)
Trial APIs (2 total)